Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Forxiga“
Suchtreffer
Begriffe & Kennungen
Forxiga · 4.8 · In the DAPA-CKD study, events of DKA were not reported in any patient in the dapagliflozin group and in 2 pati
Eintrag öffnenForxiga · 4.8 · In the DAPA-CKD study, major events of hypoglycaemia were reported in 14 (0.7%) patients in the dapagliflozin
Eintrag öffnenForxiga · 4.8 · In the DAPA-CKD study, the numbers of patients with events suggestive of volume depletion were 120 (5.6%) in t
Eintrag öffnenForxiga · 4.8 · In the DAPA-CKD study, there were 3 (0.1%) patients with serious adverse events of genital infections in the d
Eintrag öffnenForxiga · 4.8 · In the DAPA-HF and DELIVER studies, eGFR decreased over time in both the dapagliflozin group and the placebo g
Eintrag öffnenForxiga · 4.8 · In the DAPA-HF study, events of DKA were reported in 3 patients with type 2 diabetes mellitus in the dapaglifl
Eintrag öffnenForxiga · 4.8 · In the DAPA-HF study, major events of hypoglycaemia were reported in 4 (0.2%) patients in both the dapaglifloz
Eintrag öffnenForxiga · 4.8 · In the DAPA-HF study, no patient reported serious adverse events of genital infections in the dapagliflozin gr
Eintrag öffnenForxiga · 4.8 · In the DAPA-HF study, the numbers of patients with events suggestive of volume depletion were 170 (7.2%) in th
Eintrag öffnenForxiga · 4.8 · In the DAPA-HF study, the numbers of patients with serious adverse events of urinary tract infections were 14
Eintrag öffnenForxiga · 4.8 · In the DECLARE study with 17,160 type 2 diabetes mellitus patients and a median exposure time of 48 months, a
Eintrag öffnenForxiga · 4.8 · In the DECLARE study, including elderly patients and patients with renal impairment (eGFR less than 60 mL/min/
Eintrag öffnenForxiga · 4.8 · In the DECLARE study, no increased risk of major hypoglycaemia was observed with dapagliflozin therapy compare
Eintrag öffnenForxiga · 4.8 · In the DECLARE study, serious events of urinary tract infections were reported less frequently for dapaglifloz
Eintrag öffnenForxiga · 4.8 · In the DECLARE study, the numbers of patients with serious adverse events of genital infections were few and b
Eintrag öffnenForxiga · 4.8 · In the dapagliflozin cardiovascular outcomes study in type 2 diabetes mellitus (DECLARE study, see section 5.1
Eintrag öffnenForxiga · 4.8 · Increased creatinine Adverse reactions related to increased creatinine were grouped (e.g. decreased renal crea
Eintrag öffnenForxiga · 4.8 · Necrotising fasciitis of the perineum (Fournier’s gangrene) Cases of Fournier’s gangrene have been reported po
Eintrag öffnenForxiga · 4.8 · Paediatric population
Eintrag öffnenForxiga · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnen